
Rating #125
Polaris Capital Management
Portfolio value
Stocks
Performance
1 Year
+6.94%
Stock Holdings
$
%
1Y
3Y
5Y
10Y
Top10 stocks: 43.93% of the portfolio
Adds
New Buys
Sold Outs
Cuts
1.34ppt
0.75ppt
0.20ppt
0.29ppt
0.26ppt
0.87ppt
0.50ppt
-0.14ppt
0.03ppt
-0.02ppt
Company Name | Share Count Chg. (%) | Price Paid | Buy Value | Portfolio % Change | |
|---|---|---|---|---|---|
1 ![]() NOMD | +138.77% | $15.67 | $31.35M | 1.34ppt | |
2 ![]() CVS | +23.71% | $68.53 | $7.92M | 0.75ppt | |
3 ![]() ELV | +37.29% | $311.02 | $7.09M | 0.20ppt | |
4 ![]() ARW | +19.43% | $125.79 | $6.89M | 0.29ppt | |
5 ![]() TSN | +20.36% | $55.21 | $5.07M | 0.26ppt | |
6 ![]() MKSI | +11.04% | $106.59 | $4.25M | 0.87ppt | |
7 ![]() MPC | +9.28% | $175.86 | $2.90M | 0.50ppt | |
8 ![]() LKQ | +11.44% | $32.85 | $2.35M | -0.14ppt | |
9 ![]() PECO | +29.00% | $34.65 | $464.31K | 0.03ppt | |
10 ![]() PRGS | +27.75% | $46.08 | $442.37K | -0.02ppt |
Company Name | Primary Industry | Avg. price paid | Share Count Chg. (%) | No of shares held | Market value | Portfolio % Change | % of Ownership | Holding period | Last Transaction | |
|---|---|---|---|---|---|---|---|---|---|---|
1 ![]() BPOP | State Commercial Banks | $39.89 | -7.59% | 886.53K | $112.60M | 7.40% 0.36ppt | 1.30% | 37 Quarters | Q3 2025 | |
2 ![]() VIPS | Retail-Catalog & Mail-Order | $14.34 | -9.39% | 5.07M | $99.54M | 6.54% 0.94ppt | 1.00% | 4 Quarters | Q3 2025 | |
3 ![]() LIN | Inorganic Chemicals | $355.51 | +0.06% | 168.37K | $79.98M | 5.26% 0.00ppt | 0.04% | 11 Quarters | Q3 2025 | |
4 ![]() SW | Paperboard Containers | $53.86 | -1.99% | 1.74M | $74.19M | 4.87% -0.23ppt | 0.33% | 4 Quarters | Q3 2025 | |
5 ![]() JAZZ | Pharmaceutical Pres | $155.28 | -19.03% | 513.47K | $67.67M | 4.45% -0.03ppt | 0.84% | 18 Quarters | Q3 2025 | |
6 ![]() UTHR | Pharmaceutical Pres | $193.42 | -4.39% | 122.05K | $51.16M | 3.36% 0.92ppt | 0.27% | 19 Quarters | Q3 2025 | |
7 ![]() MKSI | Industrial Instruments | $90.81 | +11.04% | 401.30K | $49.67M | 3.26% 0.87ppt | 0.60% | 23 Quarters | Q3 2025 | |
8 ![]() CVS | Retail-Drug Stores | $69.70 | +23.71% | 602.60K | $45.43M | 2.99% 0.75ppt | 0.05% | 20 Quarters | Q3 2025 | |
9 ![]() NOMD | Food Products | $16.06 | +138.77% | 3.44M | $45.26M | 2.97% 1.34ppt | 2.26% | 15 Quarters | Q3 2025 | |
10 ![]() JPM | National Banks | $87.98 | -9.48% | 136.46K | $43.04M | 2.83% -0.08ppt | 0.01% | 37 Quarters | Q3 2025 | |
11 ![]() ARW | Wholesale-Electronic Parts | $85.17 | +19.43% | 336.90K | $40.77M | 2.68% 0.29ppt | 0.64% | 23 Quarters | Q3 2025 | |
12 ![]() SLM | Personal Credit Institutions | $18.61 | -3.36% | 1.41M | $39.06M | 2.57% -0.62ppt | 0.67% | 15 Quarters | Q3 2025 | |
13 ![]() IBOC | State Commercial Banks | $34.40 | -4.81% | 546.00K | $37.54M | 2.47% -0.07ppt | 0.88% | 44 Quarters | Q3 2025 | |
14 ![]() MPC | Petroleum Refining | $64.79 | +9.28% | 194.33K | $37.46M | 2.46% 0.50ppt | 0.06% | 44 Quarters | Q3 2025 | |
15 ![]() CG | Investment Advice | $34.15 | -7.82% | 578.60K | $36.28M | 2.38% 0.24ppt | 0.16% | 14 Quarters | Q3 2025 | |
16 ![]() WBS | National Banks | $39.31 | -2.66% | 607.10K | $36.09M | 2.37% 0.11ppt | 0.37% | 44 Quarters | Q3 2025 | |
17 ![]() GD | Ship & Boat Building | $167.46 | -5.80% | 103.85K | $35.41M | 2.33% 0.19ppt | 0.04% | 44 Quarters | Q3 2025 | |
18 ![]() GILD | Biological products | $62.81 | -3.85% | 312.40K | $34.68M | 2.28% -0.12ppt | 0.03% | 13 Quarters | Q3 2025 | |
19 ![]() SBH | Other Retail-Stores | $14.77 | -2.69% | 2.06M | $33.54M | 2.20% 0.90ppt | 2.05% | 15 Quarters | Q3 2025 | |
20 ![]() ABBV | Pharmaceutical Pres | $106.09 | -7.01% | 141.94K | $32.87M | 2.16% 0.27ppt | 0.01% | 22 Quarters | Q3 2025 |
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.